Cargando…

Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis

Multiple sclerosis (MS) predominantly affects women of fertile age. Various aspects of MS could impact on fertility, such as sexual dysfunction, endocrine alterations, autoimmune imbalances, and disease-modifying therapies (DMTs). The proportion of women with MS (wMS) requesting infertility manageme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sparaco, Maddalena, Carbone, Luigi, Landi, Doriana, Ingrasciotta, Ylenia, Di Girolamo, Raffaella, Vitturi, Giacomo, Marfia, Girolama Alessandra, Alviggi, Carlo, Bonavita, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570169/ https://www.ncbi.nlm.nih.gov/pubmed/37679579 http://dx.doi.org/10.1007/s40263-023-01036-1

Ejemplares similares

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2022)

The Role of Wearable Devices in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2018)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod
por: Barbano, Lucilla, et al.
Publicado: (2021)

Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
por: Petracca, Maria, et al.
Publicado: (2022)

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis
por: Ziccardi, Lucia, et al.
Publicado: (2020)

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
por: Landi, Doriana, et al.
Publicado: (2020)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study †
por: Miele, Giuseppina, et al.
Publicado: (2023)

Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration
por: Barbano, Lucilla, et al.
Publicado: (2022)

Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey
por: Landi, Doriana, et al.
Publicado: (2021)

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
por: Iannetta, Marco, et al.
Publicado: (2021)

Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy
por: Parisi, Vincenzo, et al.
Publicado: (2023)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment
por: Prezioso, Carla, et al.
Publicado: (2021)

Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
por: Landi, Doriana, et al.
Publicado: (2022)

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis
por: Martucci, Alessio, et al.
Publicado: (2021)

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021)

Maternal Multiple Sclerosis and Offspring’s Cognitive and Behavioral Development: What Do We Know until Now?
por: Siracusano, Martina, et al.
Publicado: (2022)

Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab
por: Iannetta, Marco, et al.
Publicado: (2020)

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications
por: Iannetta, Marco, et al.
Publicado: (2022)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment
por: Prezioso, Carla, et al.
Publicado: (2022)

Reproduction and Infertility III Symposium
por: Mastroianni, Luigi
Publicado: (1959)

Severe Ovarian Hyperstimulation Syndrome in a Woman With Breast Cancer Under Letrozole Triggered With GnRH Agonist: A Case Report and Review of the Literature
por: Iorio, Giuseppe Gabriele, et al.
Publicado: (2021)

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients
por: Severa, Martina, et al.
Publicado: (2023)

Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Family Planning Decision Making in People With Multiple Sclerosis
por: Bonavita, Simona, et al.
Publicado: (2021)

Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Whole-Brain Propagation Delays in Multiple Sclerosis, a Combined Tractography-Magnetoencephalography Study
por: Sorrentino, P., et al.
Publicado: (2022)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hjv8j1jtlgmme0rii4as3aoa77